Supplementary Figure S4 from Phase I Study of SYNB1891, an Engineered <i>E. coli</i> Nissle Strain Expressing STING Agonist, with and without Atezolizumab in Advanced Malignancies

crossref（2023）

引用 0|浏览6

暂无评分

摘要

Supplemental Figure 4. SYNB1891 increases IFN-stimulated gene expression in mouse tumors.

查看译文

AI 理解论文

溯源树

样例

生成溯源树，研究论文发展脉络

Chat Paper

正在生成论文摘要

Supplementary Figure S4 from Phase I Study of SYNB1891, an Engineered &lt;i&gt;E. coli&lt;/i&gt; Nissle Strain Expressing STING Agonist, with and without Atezolizumab in Advanced Malignancies